• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
LGVN

LGVN

Longeveron Inc.

NASDAQHealthcareBiotechnologyUS

USD0.80

+0.04 (+5.26%)

Rating:C

Company Profile

CEO

Stephen H. Willard

IPO Date

2021-02-12

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.77

Prev. Close

$0.76

Day Low

$0.76

Day High

$0.83

52W Low

$0.47

52W High

$1.80

Market Cap

$0.02B

Volume

0.33M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

32.2%

Avg Negative

1.8%

Avg Neutral

66.2%

News Feed

Longeveron's Novel Therapy Looks to Tackle COVID-19, Flu-Related ARDS

Benzinga·7/29/2021·↑ positive

Longeveron's Founders Hopeful That With Continued Clinical Trial Success, Lomecel-B May Win Regulatory Approval

Benzinga·7/7/2021·↑ positive

Longeveron Announces Two Abstracts Accepted for Presentation at the Gerontological Society of America 2021 Annual Scientific Meeting

GlobeNewsWire·6/30/2021·↑ positive

Longeveron, Armed with Positive Results of Phase I Clinical Study of Lomecel-B Cell Therapy for Alzheimer's Disease, Presenting at AAIC & Headed to Phase 2 Trials

Benzinga·6/28/2021·↑ positive

Longeveron Announces Abstract Highlighting Data from Phase 1 Alzheimer's Disease Trial Accepted for Developing Topics Presentation at the 2021 Annual Alzheimer's Association International Conference

Benzinga·6/24/2021·↑ positive

Longeveron's (LGVN) CEO Geoff Green on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/14/2021·↓ negative

Longeveron Inc. Provides Corporate Update and Reports First Quarter 2021 Financial Results

GlobeNewsWire·5/14/2021·↑ positive

Longeveron: A High-Quality Emerging Biotech Play

GuruFocus·4/13/2021·↑ positive

LGVN Stock: Over 25% Increase Pre-Market Explanation

Pulse2·4/13/2021·↑ positive

SmallCapsDaily: Longeveron Inc. Emerges as a True Blue Bio-Tech Titan

Newsfile Corp·4/12/2021·↑ positive